Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,587 | 7,914 | -179,389 | 20,329 | 17,117 |
| Depreciation Amortization | 12,674 | 3,623 | 186,178 | 12,231 | 8,560 |
| Income taxes - deferred | 28,447 | 6,679 | -23,329 | 4,510 | 1,153 |
| Other Working Capital | -188,238 | 1,449 | 470,748 | 261,311 | 309,004 |
| Other Operating Activity | -3,294 | 1,546 | 4,693 | 3,338 | 1,697 |
| Operating Cash Flow | $-166,998 | $21,211 | $458,901 | $301,719 | $337,531 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -302 | -135 | -995 | -721 | -641 |
| Other Investing Activity | -340 | 0 | -19 | -19 | -13 |
| Investing Cash Flow | $-642 | $-135 | $-1,014 | $-740 | $-654 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 460,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -3,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 216 | 216 | 216 |
| Dividend Paid | N/A | N/A | -18,601 | -18,601 | -12,268 |
| Other Financing Activity | -329,825 | -322 | -24,650 | -24,650 | -24,650 |
| Financing Cash Flow | $127,175 | $-322 | $-43,035 | $-43,035 | $-36,702 |
| Beginning Cash Position | 491,885 | 491,885 | 77,033 | 77,033 | 77,033 |
| End Cash Position | 451,420 | 512,639 | 491,885 | 334,977 | 377,208 |
| Net Cash Flow | $-40,465 | $20,754 | $414,852 | $257,944 | $300,175 |
| Free Cash Flow | |||||
| Operating Cash Flow | -166,998 | 21,211 | 458,901 | 301,719 | 337,531 |
| Capital Expenditure | -302 | -135 | -995 | -721 | -641 |
| Free Cash Flow | -167,300 | 21,076 | 457,906 | 300,998 | 336,890 |